Africa Malaria Diagnosis & Treatment Market Research Report Information, by Diagnosis (Rapid Diagnostic Tests (RDT’s), Molecular diagnostics, Microscopy), by Malarial Parasite (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae and Plasmodium Ovale) - Forecast till 2032

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Africa Malaria Diagnosis & Treatment Market, by Technique

5.1 Introduction

5.1.1 Rapid Diagnostic Tests (RDT’s),

5.1.2 Molecular diagnostics

5.1.3 Microscopy

6 Africa Malaria Diagnosis & Treatment Market, by Malarial Parasite

6.1 Introduction

6.1.1 Plasmodium Falciparum

6.1.2 Plasmodium Vivax

6.1.3 Plasmodium Malariae

6.1.4 Plasmodium Ovale

7 Africa Medical Devices Market, by Country

7.1 Introduction

7.2 Angola

7.3 Benin

7.4 Nigeria

7.5 Burkina Faso

7.6 Democratic Republic of the Congo

7.7 Ethiopia

7.8 Cote d'Ivoire

7.9 Ghana

8 Company Landscape

8.1 Introduction

8.1.1 Mergers Acquisitions

8.1.2 Collaborations

8.1.3 Release/New Product Launches

8.1.4 Other (Expansion, Updates, Partnership)

9 Company Profile

9.1 Alere Inc.

9.1.1 Company Overview

9.1.2 Product/Business Segment Overview

9.1.3 Financials

9.1.4 Key Developments

9.1.5 SWOT Analysis

9.2 Access Bio Inc.

9.2.1 Overview

9.2.2 Product/Business Segment Overview

9.2.3 Financials

9.2.4 Key Developments

9.2.5 SWOT Analysis

9.3 Premier Medical Corporation

9.3.1 Overview

9.3.2 Product/Business Segment Overview

9.3.3 Financials

9.3.4 Key Developments

9.3.5 SWOT Analysis

9.4 Beckman Coulter/Danaher

9.4.1 Overview

9.4.2 Product/Business Segment Overview

9.4.3 Financials

9.4.4 Key Developments

9.4.5 SWOT Analysis

9.5 BioMerieux

9.5.1 Overview

9.5.2 Product/Business Segment Overview

9.5.3 Financials

9.5.4 Key Developments

9.5.5 SWOT Analysis

9.6 Novartis Diagnostics

9.6.1 Overview

9.6.2 Product/Business Segment Overview

9.6.3 Financials

9.6.4 Key Developments

9.6.5 SWOT Analysis

9.7 Siemens Healthcare

9.7.1 Overview

9.7.2 Product/Business Segment Overview

9.7.3 Financials

9.7.4 Key Developments

9.7.5 SWOT Analysis

9.8 Bio-Rad Laboratories

9.8.1 Overview

9.8.2 Product/Business Segment Overview

9.8.3 Financials

9.8.4 Key Developments

9.8.5 SWOT Analysis

9.9 Cipla Inc.

9.9.1 Overview

9.9.2 Product/Business Segment Overview

9.9.3 Financials

9.9.4 Key Developments

9.9.5 SWOT Analysis

9.9 Ipca Laboratories Ltd.

9.9.1 Overview

9.9.2 Product/Business Segment Overview

9.9.3 Financials

9.9.4 Key Developments

9.9.5 SWOT Analysis

9.11 Pfizer Inc

9.11.1 Overview

9.11.2 Product/Business Segment Overview

9.11.3 Financials

9.11.4 Key Developments

9.11.5 SWOT Analysis

9.12 Sun Pharmaceutical Industries Ltd

9.12.1 Overview

9.12.2 Product/Business Segment Overview

9.12.3 Financials

9.12.4 Key Developments

9.12.5 SWOT Analysis

9.13 Sanofi

9.13.1 Overview

9.13.2 Product/Business Segment Overview

9.13.3 Financials

9.13.4 Key Developments

9.13.5 SWOT Analysis

9.14 Others

10 Appendix

List of Tables

TABLE 1 AFRICA MALARIA DIAGNOSIS & TREATMENT MARKET, 2020-2027 (USD MILLION)

TABLE 2 AFRICA MALARIA DIAGNOSIS & TREATMENT MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)

TABLE 3 AFRICA MALARIA DIAGNOSIS & TREATMENT MARKET, BY MALARIAL PARASITE, 2020-2027 (USD MILLION)

TABLE 4 AFRICA MALARIA DIAGNOSIS & TREATMENT MARKET, BY REGION, 2020-2027 (USD MILLION)

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 AFRICA MALARIA DIAGNOSIS & TREATMENT MARKET, BY TECHNIQUE

FIGURE 4 AFRICA MALARIA DIAGNOSIS & TREATMENT MARKET, BY MALARIAL PARASITE

FIGURE 5 AFRICA MALARIA DIAGNOSIS & TREATMENT MARKET, BY REGION

FIGURE 6 AFRICA MALARIA DIAGNOSIS & TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)